Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Optimizing Amplex Red for Precision Redox Biology Translatio
2026-07-03
This thought-leadership article examines the mechanistic underpinnings and translational utility of Amplex Red (10-Acetyl-3,7-dihydroxyphenoxazine) for hydrogen peroxide and reactive oxygen species detection. Drawing on recent protocol advancements and critical literature, we deliver strategic guidance for researchers seeking to bridge basic redox discovery with robust, clinically relevant oxidative stress monitoring. Special attention is given to assay specificity, emerging pitfalls, and practical solutions for high-throughput and translational workflows.
-
METTL17 Modulates Ferroptosis via Mitochondrial Translation
2026-07-03
This study uncovers how METTL17, a mitochondrial protein, orchestrates resistance to ferroptosis and supports tumorigenesis in colorectal cancer by regulating mitochondrial RNA methylation and translation. The findings identify METTL17 as a promising target for sensitizing colorectal tumors to ferroptosis-based therapies and highlight new mechanistic links between mitochondrial function and cancer cell survival.
-
Deferasirox Fe3+ Chelate: Protocols for Iron Overload Resear
2026-07-02
Deferasirox Fe3+ chelate empowers researchers to precisely model iron overload and chelation in chronic anemia and beta-thalassemia studies. This guide details advanced workflows, troubleshooting tactics, and protocol parameters that leverage APExBIO's high-purity, DMSO-soluble Exjade formulation for reproducible, high-impact results.
-
Anlotinib Hydrochloride: Advanced Protocols for Cancer Resea
2026-07-02
Anlotinib hydrochloride is a next-generation multi-target tyrosine kinase inhibitor optimized for reproducible angiogenesis and tumor biology workflows. Its uniquely potent inhibition of VEGFR2, PDGFRβ, and FGFR1, combined with superior selectivity and safety, makes it a strategic asset for experimental and translational cancer research.
-
Neticonazole Hydrochloride: Dual-Action Imidazole Antifungal
2026-07-01
Neticonazole Hydrochloride streamlines both mycology and oncology research, uniquely supporting topical therapy for cutaneous candidiasis and advanced colorectal cancer models. Explore data-driven protocol enhancements, troubleshooting strategies, and cross-domain applications that set this imidazole antifungal apart.
-
SR-202: Applied Workflows for PPARγ Antagonism in Immunometa
2026-07-01
SR-202, a selective PPARγ antagonist, empowers researchers to dissect insulin resistance and macrophage polarization with high specificity. This guide details experimental protocols and troubleshooting insights, translating the latest reference findings into actionable strategies for obesity and type 2 diabetes models.
-
Annexin V-Cy5/DAPI Apoptosis Kit: Precision in Cell Death As
2026-06-30
The Annexin V-Cy5/DAPI Apoptosis Kit empowers fast, highly specific quantification of apoptosis and necrosis, streamlining complex cell death investigations. Leveraging dual-channel fluorescence and robust protocol design, this kit advances translational research in oncology and immunology.
-
Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit
2026-06-30
The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit addresses the difficulty of resolving low molecular weight proteins and peptides (1–10 kDa) that are not efficiently separated by conventional Tris-glycine SDS-PAGE. This kit is intended strictly for research workflows and should not be used for diagnostic or clinical applications.
-
Applied Workflows for Cardiogreen (Indocyanine Green) in Dia
2026-06-29
Cardiogreen (Indocyanine Green) enables precision vascular imaging and advanced photodynamic therapy, seamlessly bridging diagnostics and immuno-oncology. Learn how optimized protocols and troubleshooting strategies can unlock its full translational potential across applied research domains.
-
DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe: Te
2026-06-29
DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe provides selective, high-contrast staining of cell plasma membranes, facilitating applications like neuronal tracing and cell migration assays. It is not suitable for aqueous-only protocols or for labeling beyond the plasma membrane, and careful handling is needed to maintain membrane specificity.
-
EZ Cap EGFP mRNA 5-moUTP: Transforming Fluorescent Gene Deli
2026-06-28
EZ Cap™ EGFP mRNA (5-moUTP) sets a new benchmark for reliable, low-immunogenicity gene expression in both in vitro and in vivo assays. Its advanced Cap1 capping, 5-moUTP modification, and robust poly(A) tail optimize translation efficiency and stability, powering next-generation workflows in gene regulation, imaging, and mRNA delivery research.
-
CFTRinh-172 in Epithelial Models: Mechanistic Insights and S
2026-06-27
This thought-leadership article explores how the selective CFTR inhibitor CFTRinh-172 empowers translational research in cystic fibrosis and secretory diarrheal diseases by enabling precise manipulation of CFTR chloride channel activity. We synthesize recent mechanistic discoveries—particularly SHC-1-mediated regulation of CFTR trafficking—offering actionable protocol guidance and strategic context for researchers. The article clarifies where CFTRinh-172 fits within the evolving competitive landscape, distinctly bridging bench discoveries with translational impact.
-
HNF4A-AS1 Loss Drives Sorafenib Resistance via Lipid Metabol
2026-06-26
This study reveals that decreased liver-specific lncRNA HNF4A-AS1 contributes to resistance against sorafenib-induced ferroptosis in hepatocellular carcinoma (HCC) by reprogramming lipid metabolism. The mechanistic insights into HNF4A-AS1's regulation of PUFA dynamics and m6A-modified DECR1 mRNA offer new therapeutic targets for overcoming drug resistance in liver cancer.
-
Gly-Gly-Phe-Gly (GGFG): Precision Linker for ADC and Drug Co
2026-06-26
Gly-Gly-Phe-Gly (GGFG) is transforming experimental workflows in drug conjugation and antibody-drug conjugate development as a reliable, flexible peptide linker. With high purity and reproducible performance, GGFG enables advanced bioconjugation strategies and facilitates troubleshooting in complex peptide engineering projects.
-
CBD Attenuates Orofacial Inflammatory Pain via Multi-Level M
2026-06-25
This study presents a comprehensive analysis of cannabidiol’s (CBD) efficacy in mitigating both sensory and affective dimensions of orofacial inflammatory pain in mice. Through a multidimensional behavioral and mechanistic approach, the research establishes CBD’s potential as a translational therapy for pain and associated emotional deficits.